Literature DB >> 25171707

Atypical central neurocytoma with sarcomatous differentiation.

Lakshmi Vemavarapu1, Irene Czyszczon, Joseph C Parker, Stephanie Wagner, Todd Vitaz, John R Parker.   

Abstract

We report a case of an intraventricular tumor with features of atypical central neurocytoma with a sarcomatous component in a 44-year-old woman who presented with headaches and vomiting. Magnetic resonance imaging revealed a 3.4-cm lobulated enhancing mass in the occipital horn of the left lateral ventricle, and the patient subsequently underwent a left occipital-parietal craniotomy for debulking. The tumor contained 2 cell populations: round cells with perinuclear halos in a fibrillary background, and spindle cells with oval nuclei arranged in interlacing fascicles with focal necrosis. The round cells had diffuse synaptophysin immunopositivity, while the spindle cells were diffusely immunopositive for vimentin and had intercellular reticulin. The mitotic activity (8 mitotic figures per 10 high-power fields) and the high Ki-67 proliferation index (15.0%) were consistent with atypical central neurocytoma with a sarcomatous component. Although different histologic variants have been described, this is the first reported case, to our knowledge, of central neurocytoma with spindle cell sarcomatous features.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25171707     DOI: 10.5858/arpa.2012-0563-CR

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  Malignant transformation of central neurocytoma with dissemination 17 years after initial treatment: illustrative case.

Authors:  Kazuhiro Kojima; Yoshiki Arakawa; Yasuhide Takeuchi; Yukinori Terada; Masahiro Tanji; Yohei Mineharu; Hironori Haga; Susumu Miyamoto
Journal:  J Neurosurg Case Lessons       Date:  2022-02-07

2.  Clinical characteristics and prognostic factors of brain central neurocytoma.

Authors:  Yaqi Song; Xinle Kang; Gang Cao; Yongqiang Li; Xilei Zhou; Yusuo Tong; Wanwei Wang
Journal:  Oncotarget       Date:  2016-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.